Institution
Danube University Krems
Education•Krems, Niederösterreich, Austria•
About: Danube University Krems is a education organization based out in Krems, Niederösterreich, Austria. It is known for research contribution in the topics: Stroke & Population. The organization has 498 authors who have published 1572 publications receiving 68797 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this paper, the influence of easy axis distribution (EAD) on magnetic properties of FePt-C granular films which were deposited on a single crystalline MgO (0,0,1) substrate and a (0,0, 1)-textured poly-crystalline mgO underlayer was studied.
49 citations
••
TL;DR: This article assessed the impact of restricting systematic reviews of conventional or alternative medical treatments or diagnostic tests to English-language publications on effect estimates and conclusions and found that restricting systematic review to English language publications appeared to have little impact on the effect estimates.
49 citations
••
Libin Cardiovascular Institute of Alberta1, North-West University2, World Health Organization3, Pan American Health Organization4, Menzies Research Institute5, Tulane University6, University of Milano-Bicocca7, State University of New York System8, National University of Cordoba9, Kaiser Permanente10, Danube University Krems11, University of Ibadan12, Medical University of South Carolina13
TL;DR: This research highlights the need to understand more fully the role of emotion in the decision-making process and the role that emotion plays in the development of knowledge and understanding.
Abstract: Norm R. C. Campbell MD1 | Aletta E. Schutte PhD2 | Cherian V. Varghese MD, PhD3 | Pedro Ordunez MD, PhD4 | Xin-Hua Zhang MD, PhD5 | Taskeen Khan MD, MMed, FCPHM3 | James E. Sharman PhD6 | Paul K. Whelton MB, MD, MSc7 | Gianfranco Parati MD8,9 | Michael A. Weber MD10 | Marcelo Orías MD, PhD11,12 | Marc G. Jaffe MD13,14 | Andrew E. Moran MD, MPH15 | Frida Liane Plavnik MD, PhD16,17,18 | Venkata S. Ram MD, FACC, MACP19,20,21,22 | Michael Brainin MD, PhD, Dr, (hons), FESO, FAHA, FEAN23 | Mayowa O. Owolabi MBBS, MSc, (distinction), DrM, (Berlin), Cert, Epid, Glob, Health, (Dundee), FMCP, FAAN, FANA, FRCP, FAS24 | Augstin J. Ramirez MD, PhD25 | Eduardo Barbosa MD, MSc26 | Luiz Aparecido Bortolotto MD, PhD27,28 | Daniel T. Lackland DrPH29
49 citations
••
TL;DR: The findings suggest that the Post Stroke Checklist is a feasible and useful measure for identifying long term stroke care needs in a clinical practice setting and is relevant to stroke survivors in pilot studies in the United Kingdom and Singapore.
Abstract: Background There is currently no standardized process for long-term follow-up care. As a result, management of post-stroke care varies greatly, and the needs of stroke survivors are not fully addressed. The Post Stroke Checklist was developed by the Global Stroke Community Advisory Panel as a means of standardizing long-term stroke care. Since its development, the Post Stroke Checklist has gained international recognition from various stroke networks and is endorsed by the World Stroke Organization to support improved stroke survivor follow-up and care. Aims The aim of this study was to evaluate the feasibility and usefulness of the Post Stroke Checklist in clinical practice and assess its relevance to stroke survivors in pilot studies in the United Kingdom and Singapore. Methods The Post Stroke Checklist was administered to stroke survivors in the United Kingdom (n = 42) and Singapore (n = 100) by clinicians. To assess the feasibility of the Post Stroke Checklist in clinical practice, an independent researcher observed the assessment and made notes relating to the patient-clinician interaction and their interpretations of the Post Stroke Checklist items. Patient and clinician satisfaction with the Post Stroke Checklist was assessed by three questions, responded to on a 0-10 numerical rating scale. Clinicians also completed a Pragmatic Face and Content Validity test to evaluate their overall impressions of the Post Stroke Checklist. In the United Kingdom, a subset of patients (n = 14) took part in a concept elicitation interview prior to being administered the Post Stroke Checklist, followed by a cognitive debriefing interview to assess relevance and comprehension of the Post Stroke Checklist. Results The Post Stroke Checklist identified frequently reported problems for stroke survivors including cognition (reported by 47.2% of patients), mood (43.7%), and life after stroke (38%). An average of 3.2 problems per patient was identified across both countries (range 0-10). An average of 5 and 2.6 problems per patient were identified in the United Kingdom and Singapore, respectively. The average time taken to administer the Post Stroke Checklist was 17 mins (standard deviation 7.5) in Singapore and 13 mins (standard deviation 7.6) in the United Kingdom. Satisfaction ratings were high for patients (8.6/10) and clinicians (7.7/10), and clinician feedback via the Pragmatic Face and Content Validity test indicated that the Post Stroke Checklist is 'useful', 'informative', and 'exhaustive'. All concepts measured by the Post Stroke Checklist were spontaneously discussed by patients during the concept elicitation interviews, suggesting that the Post Stroke Checklist is relevant to stroke survivors. Cognitive debriefing data indicated that the items were generally well understood and relevant to stroke. Minor revisions were made to the Post Stroke Checklist based on patient feedback. Conclusions The findings suggest that the Post Stroke Checklist is a feasible and useful measure for identifying long term stroke care needs in a clinical practice setting. Pilot testing indicated that the Post Stroke Checklist is able to identify a wide range of unmet needs, and patient and clinician feedback indicated a high level of satisfaction with the Post Stroke Checklist assessment. The items were generally well understood and considered relevant to stroke survivors, indicating the Post Stroke Checklist is a feasible, useful, and relevant measure of poststroke care. (Less)
49 citations
••
TL;DR: In this study, intravenous rt-PA treatment was beneficial for patients with mild deficit and might serve as an incentive for future randomized controlled trials to provide a basis for optimal patient selection.
Abstract: Background and Purpose—Apart from missing the approved time window of 4.5 hours, one frequent cause for withholding recombinant tissue plasminogen activator (rt-PA) treatment in patients with ischemic stroke is presentation with mild deficit on admission. We analyzed in a large cohort of patients whether rt-PA treatment is beneficial for this group of patients. Methods—From a total of 54 917 patients with ischemic stroke prospectively enrolled in the Austrian Stroke Unit Registry, 890 patients with mild deficit defined as ≤5 points in the National Institutes of Health Stroke Scale treated with and without rt-PA were matched for age, sex, prestroke disability, stroke severity, hypertension, diabetes mellitus, hypercholesterolemia, stroke cause, and clinical stroke syndrome. Functional outcome was assessed using the modified Rankin Scale at 3 months. For data visualization, weighted averages of outcome differences were computed for all age severity combinations and mapped to a color. For quantification of e...
48 citations
Authors
Showing all 514 results
Name | H-index | Papers | Citations |
---|---|---|---|
Jaakko Tuomilehto | 115 | 1285 | 210682 |
Massimo Zeviani | 104 | 478 | 39743 |
J. Tuomilehto | 69 | 197 | 19801 |
Manfred Reichert | 67 | 695 | 19569 |
Roland W. Scholz | 64 | 289 | 15387 |
Michael Brainin | 55 | 215 | 44194 |
Gerald Gartlehner | 54 | 295 | 15320 |
Thomas Schrefl | 50 | 403 | 10867 |
Charity G. Moore | 50 | 179 | 11040 |
Josef Finsterer | 48 | 1479 | 13836 |
Silvia Miksch | 44 | 264 | 7790 |
J. Tuomilehto | 44 | 107 | 11425 |
Heinrich Schima | 43 | 249 | 5973 |
Reinhard Bauer | 40 | 228 | 5435 |
Thomas Groth | 38 | 186 | 5191 |